Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 Oct;24(4):511–518. doi: 10.1111/j.1365-2125.1987.tb03205.x

Evaluation of a microcomputer program (OPT) for parameter optimisation in clinical pharmacokinetics: gentamicin and tobramycin.

F A Zantvoort 1, J H Wagenvoort 1, F H Derkx 1, M F Michel 1
PMCID: PMC1386314  PMID: 3689631

Abstract

1. Several nomograms and computer programs are available to aid in aminoglycoside dosing. 2. Due to the variability in the relationship between dosage and serum drug levels, monitoring through the acquisition of serum drug levels is mandatory. 3. All clinical data, including serum drug levels, are subject to errors. 4. The program we have evaluated, OPT, calculates the most likely set of pharmacokinetic parameter estimates for individual patients by applying Bayes' theorem and the principle of Maximum Likelihood Estimation. Through a feedback process all available data are used, taking possible errors into account. 5. Our study shows that OPT is able to predict serum aminoglycoside levels accurately in the routine clinical setting. It may thus contribute to the quality of aminoglycoside therapy.

Full text

PDF
511

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barza M., Brown R. B., Shen D., Gibaldi M., Weinstein L. Predictability of blood levels of gentamicin in man. J Infect Dis. 1975 Aug;132(2):165–174. doi: 10.1093/infdis/132.2.165. [DOI] [PubMed] [Google Scholar]
  2. Chan R. A., Benner E. J., Hoeprich P. D. Gentamicin therapy in renal failure: a nomogram for dosage. Ann Intern Med. 1972 May;76(5):773–778. doi: 10.7326/0003-4819-76-5-773. [DOI] [PubMed] [Google Scholar]
  3. Davey P. G., Geddes A. M., Gonda I., Harpur E. S., Scott D. K. Comparison of methods for estimating gentamicin clearance and retrospective analysis of changes in clearance with emphasis on patients with normal renal function. Br J Clin Pharmacol. 1984 Feb;17(2):147–155. doi: 10.1111/j.1365-2125.1984.tb02329.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gorsky J. E., Latts J. R. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy. Ther Drug Monit. 1983 Jun;5(2):169–172. [PubMed] [Google Scholar]
  5. Hatton R. C., Massey K. L., Russell W. L. Comparison of the predictions of one- and two-compartment microcomputer programs for long-term tobramycin therapy. Ther Drug Monit. 1984;6(4):432–437. doi: 10.1097/00007691-198412000-00009. [DOI] [PubMed] [Google Scholar]
  6. Hull J. H., Sarubbi F. A., Jr Gentamicin serum concentrations: pharmacokinetic predictions. Ann Intern Med. 1976 Aug;85(2):183–189. doi: 10.7326/0003-4819-85-2-183. [DOI] [PubMed] [Google Scholar]
  7. Jelliffe R. W. Letter: Creatinine clearance: bedside estimate. Ann Intern Med. 1973 Oct;79(4):604–605. doi: 10.7326/0003-4819-79-4-604. [DOI] [PubMed] [Google Scholar]
  8. Kaye D., Levison M. E., Labovitz E. D. The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function. J Infect Dis. 1974 Aug;130(2):150–154. doi: 10.1093/infdis/130.2.150. [DOI] [PubMed] [Google Scholar]
  9. Kelman A. W., Whiting B., Bryson S. M. OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics. Br J Clin Pharmacol. 1982 Aug;14(2):247–256. doi: 10.1111/j.1365-2125.1982.tb01969.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kelman A. W., Whiting B., Bryson S. M. Parameter optimisation in clinical pharmacokinetics. Comput Programs Biomed. 1982 Jun;14(3):239–248. doi: 10.1016/0010-468x(82)90029-0. [DOI] [PubMed] [Google Scholar]
  11. Noone P., Parsons T. M., Pattison J. R., Slack R. C., Garfield-Davies D., Hughes K. Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J. 1974 Mar 16;1(5906):477–481. doi: 10.1136/bmj.1.5906.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Regamey C., Gordon R. C., Kirby W. M. Comparative pharmacokinetics of tobramycin and gentamicin. Clin Pharmacol Ther. 1973 May-Jun;14(3):396–403. doi: 10.1002/cpt1973143396. [DOI] [PubMed] [Google Scholar]
  13. Reymann M. T., Bradac J. A., Cobbs C. G., Dismukes W. E. Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary disease. Antimicrob Agents Chemother. 1979 Sep;16(3):353–361. doi: 10.1128/aac.16.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ristuccia A. M., Cunha B. A. The aminoglycosides. Med Clin North Am. 1982 Jan;66(1):303–312. doi: 10.1016/s0025-7125(16)31462-6. [DOI] [PubMed] [Google Scholar]
  15. Schentag J. J., Adelman M. H. A microcomputer program for tobramycin consult services, based on the two-compartment pharmacokinetic model. Drug Intell Clin Pharm. 1983 Jul-Aug;17(7-8):528–531. doi: 10.1177/106002808301700706. [DOI] [PubMed] [Google Scholar]
  16. Schloemer J. H., Zagozen J. J. Cost analysis of an aminoglycoside pharmacokinetic dosing program. Am J Hosp Pharm. 1984 Nov;41(11):2347–2351. [PubMed] [Google Scholar]
  17. Sheiner L. B., Rosenberg B., Marathe V. V. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm. 1977 Oct;5(5):445–479. doi: 10.1007/BF01061728. [DOI] [PubMed] [Google Scholar]
  18. Whiting B., Kelman A. W., Bryson S. M., Derkx F. H., Thomson A. H., Fotheringham G. H., Joel S. E. Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribing. Br Med J (Clin Res Ed) 1984 Feb 18;288(6416):541–545. doi: 10.1136/bmj.288.6416.541. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES